imipramine has been researched along with neuropeptide y in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG | 1 |
| Legutko, B; Smiałowska, M | 1 |
| Ekman, R; Heilig, M; Wahlestedt, C; Widerlöv, E | 1 |
| Agnati, LF; Cummins, JT; Fuxe, K; Ogren, SO; von Euler, G | 1 |
| Ekman, R; Heilig, M | 1 |
| Bellmann, R; Sperk, G | 1 |
| Baker, RA; Brady, LS; Herkenham, M | 1 |
| Ishida, H; Iwata, M; Kawahara, R; Shirayama, Y | 1 |
| Bhisikar, SM; Goyal, SN; Kokare, DM; Subhedar, NK; Upadhya, MA | 1 |
| Crespi, F | 1 |
| Bharne, AP; Kokare, DM; Nakhate, KT; Subhedar, NK; Yedke, SU | 1 |
11 other study(ies) available for imipramine and neuropeptide y
| Article | Year |
|---|---|
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship | 2008 |
Influence of imipramine on neuropeptide Y immunoreactivity in the rat brain.
Topics: Animals; Brain; Cerebral Cortex; Dose-Response Relationship, Drug; Hypothalamus; Imipramine; Immunohistochemistry; Male; Neuropeptide Y; Rats; Rats, Inbred Strains; Reference Values | 1991 |
Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain.
Topics: Animals; Brain Chemistry; Imipramine; Male; Neuropeptide Y; Rats; Rats, Inbred Strains; Zimeldine | 1988 |
Chronic imipramine treatment reduces (+)2-[125I]iodolysergic acid, diethylamide but not 125I-neuropeptide Y binding in layer IV of rat cerebral cortex.
Topics: Animals; Autoradiography; Cerebral Cortex; Imipramine; Lysergic Acid Diethylamide; Male; Neuropeptide Y; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1987 |
Chronic parenteral antidepressant treatment in rats: unaltered levels and processing of neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH).
Topics: Analysis of Variance; Animals; Antidepressive Agents; Corticotropin-Releasing Hormone; Imipramine; Injections, Intraperitoneal; Male; Neuropeptide Y; Rats; Rats, Wistar; Time Factors; Zimeldine | 1995 |
Effects of antidepressant drug treatment on levels of NPY or prepro-NPY-mRNA in the rat brain.
Topics: Animals; Antidepressive Agents, Tricyclic; Blotting, Northern; Brain; Clomipramine; Desipramine; Frontal Lobe; Hippocampus; Imipramine; Male; Neuropeptide Y; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1993 |
Effects of long-term treatment with antidepressant drugs on proopiomelanocortin and neuropeptide Y mRNA expression in the hypothalamic arcuate nucleus of rats.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Arcuate Nucleus of Hypothalamus; Fluoxetine; Gene Expression; Idazoxan; Image Processing, Computer-Assisted; Imipramine; In Situ Hybridization; Male; Neuropeptide Y; Phenelzine; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors | 1996 |
Subchronic treatment with imipramine ameliorates the decreased number in neuropeptide Y-positive cells in the hippocampus of learned helplessness rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Calcitonin Gene-Related Peptide; Cell Count; Drug Administration Schedule; Helplessness, Learned; Hippocampus; Imipramine; Interneurons; Male; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Restraint, Physical | 2005 |
Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Arginine; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Imipramine; Injections, Intraperitoneal; Injections, Intraventricular; Male; Neuropeptide Y; Olfactory Bulb; Psychomotor Agitation; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 2009 |
Influence of Neuropeptide Y and antidepressants upon cerebral monoamines involved in depression: an in vivo electrochemical study.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety; Arginine; Biogenic Monoamines; Biosensing Techniques; Brain Chemistry; Catecholamines; Depression; Electrochemistry; Fluoxetine; Imipramine; Indoles; Male; Neuropeptide Y; Neuropeptides; Oxidation-Reduction; Peptide Fragments; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Selective Serotonin Reuptake Inhibitors | 2011 |
Evidence for the involvement of neuropeptide Y in the antidepressant effect of imipramine in type 2 diabetes.
Topics: Animals; Antidepressive Agents, Tricyclic; Arginine; Blood Glucose; Central Amygdaloid Nucleus; Depression; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Imipramine; Male; Mice; Motor Activity; Neuropeptide Y; Nucleus Accumbens; Receptors, Neuropeptide Y; Septal Nuclei; Streptozocin | 2016 |